Viewing StudyNCT06025214



Ignite Creation Date: 2024-05-06 @ 7:28 PM
Last Modification Date: 2024-10-26 @ 3:07 PM
Study NCT ID: NCT06025214
Status: RECRUITING
Last Update Posted: 2023-09-06
First Post: 2023-08-29

Brief Title: Bioequivalence Study for Fluticasone Propionate 500 mcgSalmeterol Xinafoate 50 mcg Inhalation Powder in Healthy Volunteers
Sponsor: Respirent Pharmaceuticals Co Ltd
Organization: Respirent Pharmaceuticals Co Ltd

Organization Data

Organization: Respirent Pharmaceuticals Co Ltd
Class: INDUSTRY
Study ID: BECRORESPAEROPK500
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: Respirent Pharmaceuticals Co Ltd
Lead Sponsor Class: INDUSTRY
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: SPONSOR
Responsible Party Affiliation: None
Old Name: None
Old Organization: None

Collaborators

Name Class
Becro Ltd INDUSTRY